Key personnel
Jérome Courcambeck, 33, senior molecular modelling scientist, Ph.D. Dr. Courcambeck is an experienced scientist in molecular modelling and chemical synthesis. He published major papers describing the molecular basis of HIV resistance. He is the project leader of HCV protease inhibitors.
Mourad Bouzidi, 32, biochemist, Ph.D. Dr. Bouzidi is specialized in molecular biology and cell culture. He is responsible for the drug screening department, which deals with enzymatic and cell culture assays.
Gilles Roche, 25, chemist.
Nolwenn Amrani, 27, graduated from a French Business School, she's in charge of funding and commercial development. She also had a double ability : she's got a training of "Industries des Produits de Santé" from the Faculty of Pharmacy of Marseille.
|
